Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Isatuximab for Platelet Transfusion Issues
Recruiting1 awardPhase < 1
Charlottesville, Virginia
This trial is testing a drug to see if it can help people with a certain type of platelet refractoriness by removing some cells in order to make platelet transfusions more effective.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.